Directive 1978/420 - Amendment of Second Directive 75/319/EEC on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products

Please note

This page contains a limited version of this dossier in the EU Monitor.

Contents

  1. Current status
  2. Key information
  3. Key dates
  4. Legislative text
  5. 31978L0420
  6. Original proposal
  7. Sources and disclaimer
  8. Full version
  9. EU Monitor

1.

Current status

This directive was in effect from May  3, 1978 until October 31, 1983.

2.

Key information

official title

Council Directive 78/420/EEC of 2 May 1978 amending Second Directive 75/319/EEC on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products
 
Legal instrument Directive
Number legal act Directive 1978/420
Original proposal COM(1977)358 EN
CELEX number1 31978L0420

3.

Key dates

Document 02-05-1978
Publication in Official Journal 11-05-1978; Special edition in Finnish: Chapter 13 Volume 008,OJ L 123, 11.5.1978,Special edition in Swedish: Chapter 13 Volume 008,Special edition in Greek: Chapter 13 Volume 007,Special edition in Portuguese: Chapter 13 Volume 008,Special edition in Spanish: Chapter 13 Volume 008
Effect 03-05-1978; Entry into force Date notif.
End of validity 31-10-1983; Implicitly repealed by 31983L0570
Notification 03-05-1978

4.

Legislative text

Avis juridique important

|

5.

31978L0420

Council Directive 78/420/EEC of 2 May 1978 amending Second Directive 75/319/EEC on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products

Official Journal L 123 , 11/05/1978 P. 0026 - 0026

Finnish special edition: Chapter 13 Volume 8 P. 0133

Greek special edition: Chapter 13 Volume 7 P. 0118

Swedish special edition: Chapter 13 Volume 8 P. 0133

Spanish special edition: Chapter 13 Volume 8 P. 0183

Portuguese special edition Chapter 13 Volume 8 P. 0183

COUNCIL DIRECTIVE of 2 May 1978 amending Second Directive 75/319/EEC on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products (78/420/EEC)

THE COUNCIL OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Economic Community, and in particular Article 100 thereof,

Having regard to the proposal from the Commission,

Having regard to the opinion of the European Parliament (1),

Having regard to the opinion of the Economic and Social Committee (2),

Whereas Second Council Directive 75/319/EEC of 20 May 1975 on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products (3) set up a Committee for Proprietary Medicinal Products, hereinafter referred to as "the Committee", and entrusted it with the task of giving opinions on whether particular proprietary medicinal products comply with the requirements of Council Directive 65/65/EEC of 26 January 1965 on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products (4);

Whereas Articles 9 and 10 of Directive 75/319/EEC provide that, where the Community procedure is to be applied, the Member State which has issued a marketing authorization shall forward a dossier to the Committee which shall forthwith forward the dossier to the competent authorities of the Member States specified by the person responsible for marketing;

Whereas experience has shown that the provision that the dossiers shall pass through the Committee instead of being sent directly to the Member States concerned results in administrative problems in the forwarding of voluminous documentation and in delays in the work of the Committee;

Whereas, in order to solve these problems and to reduce the delays, it is necessary to amend these provisions to enable the Member State which initially issued the marketing authorization to send the dossier directly to the Member States concerned as well as to the Committee,

HAS ADOPTED THIS DIRECTIVE:

Article 1

The following shall be substituted for Article 9 of Directive 75/319/EEC:

"Article 9 1. The Member State which has issued a marketing authorization for a proprietary medicinal product shall, if the person responsible for marketing has requested forwarding to at least five other Member States, forward a dossier containing a copy of this request and a copy of the authorization together with the particulars and documents listed in the second paragraph of Article 4 of Directive 65/65/EEC to the Committee and to the competent authorities of the Member States specified.

  • 2. 
    Such forwarding shall be deemed to be equivalent to the submission of an application for marketing authorization, within the meaning of Article 4 of Directive 65/65/EEC, to the said authorities.
  • 3. 
    The Committee shall without delay inform the Member States concerned that the dossier has been received by the Committee."

Article 2

In Article 10 (1) of Directive 75/319/EEC the words "transmission of the information referred to in Article 9 (3)" shall be substituted for "forwarding referred to in Article 9 (2)".

Article 3

This Directive is addressed to the Member States.

Done at Brussels, 2 May 1978.

For the Council

The President

K.B. ANDERSEN (1)OJ No C...


More

This text has been adopted from EUR-Lex.

6.

Original proposal

  • COM(1977)358 -
 

7.

Sources and disclaimer

For further information you may want to consult the following sources that have been used to compile this dossier:
  • dossier EUR-Lex decision2

This dossier is compiled each night drawing from aforementioned sources through automated processes. We have invested a great deal in optimising the programming underlying these processes. However, we cannot guarantee the sources we draw our information from nor the resulting dossier are without fault.

 

8.

Full version

This page is also available in a full version containing the legal context, de Europese rechtsgrond, other dossiers related to the dossier at hand and the related cases of the European Court of Justice.

The full version is available for registered users of the EU Monitor by ANP and PDC Informatie Architectuur.

9.

EU Monitor

The EU Monitor enables its users to keep track of the European process of lawmaking, focusing on the relevant dossiers. It automatically signals developments in your chosen topics of interest. Apologies to unregistered users, we can no longer add new users.This service will discontinue in the near future.


  • 1. 
    Deze databank van de Europese Unie biedt de mogelijkheid de actuele werkzaamheden (workflow) van de Europese instellingen (Europees Parlement, Raad, ESC, Comité van de Regio's, Europese Centrale Bank, Hof van Justitie enz.) te volgen. EURlex volgt alle voorstellen (zoals wetgevende en begrotingsdossiers) en mededelingen van de Commissie, vanaf het moment dat ze aan de Raad of het Europees Parlement worden voorgelegd.
     
  • 2. 
    EUR-lex provides an overview of the proposal, amendments, citations and legality.